Abstract
Background: Axillary ultrasound (US) with fine needle aspiration biopsy (FNAB) of suspicious lymph nodes helps identify patients (pts) with axillary metastases preoperatively, avoiding a 2-step axillary procedure. However, it does not accurately differentiate between low and high axillary tumor burden. Our aim was to determine the rationale of preoperative axillary US in screen-detected breast cancer by finding out the proportion of screen-detected pts in whom axillary US changes axillary surgical approach and to evaluate the potential of overtreatment as a consequence of a positive FNAB in pts that otherwise meet the ACOSOG Z0011 eligibility criteria.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
